292 related articles for article (PubMed ID: 21938531)
21. Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.
Gonzalez-Angulo AM; Cristofanilli M; Strom EA; Buzdar AU; Kau SW; Broglio KR; Smith TL; Hortobagyi GN
Cancer; 2004 Oct; 101(8):1760-6. PubMed ID: 15386311
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of gamma knife radiosurgery, bi-modality & tri-modality treatment regimens for patients with one or multiple brain metastases: the Columbia University Medical Center experience.
Wang TJ; Saad S; Qureshi YH; Jani A; Isaacson SR; Sisti MB; Bruce JN; McKhann GM; Lesser J; Cheng SK; Clifford Chao KS; Lassman AB
J Neurooncol; 2015 Apr; 122(2):399-408. PubMed ID: 25687652
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
25. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
Altundag K; Bondy ML; Mirza NQ; Kau SW; Broglio K; Hortobagyi GN; Rivera E
Cancer; 2007 Dec; 110(12):2640-7. PubMed ID: 17960791
[TBL] [Abstract][Full Text] [Related]
27. Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy.
Song J; Samant R; Jay M; Chaudry H; Fan XY; MacDonald D; Bence-Bruckler I; Nair V
Support Care Cancer; 2020 Nov; 28(11):5363-5369. PubMed ID: 32140974
[TBL] [Abstract][Full Text] [Related]
28. Gamma knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy.
Serizawa T; Iuchi T; Ono J; Saeki N; Osato K; Odaki M; Ushikubo O; Hirai S; Sato M; Matsuda S
J Neurosurg; 2000 Dec; 93 Suppl 3():32-6. PubMed ID: 11143259
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
[TBL] [Abstract][Full Text] [Related]
30. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
[TBL] [Abstract][Full Text] [Related]
31. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
Le Rhun E; Bertrand N; Dumont A; Tresch E; Le Deley MC; Mailliez A; Preusser M; Weller M; Revillion F; Bonneterre J
Eur J Cancer; 2017 Dec; 87():189-198. PubMed ID: 29103666
[TBL] [Abstract][Full Text] [Related]
32. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
33. Gamma knife radiosurgery in patients with advanced breast cancer undergoing bone marrow transplant.
Levin KJ; Youssef EF; Sloan AE; Patel R; Zabad RK; Zamorano L
J Neurosurg; 2002 Dec; 97(5 Suppl):663-5. PubMed ID: 12507116
[TBL] [Abstract][Full Text] [Related]
34. Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases.
Leyland-Jones B
J Clin Oncol; 2009 Nov; 27(31):5278-86. PubMed ID: 19770385
[TBL] [Abstract][Full Text] [Related]
35. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
[TBL] [Abstract][Full Text] [Related]
36. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
[TBL] [Abstract][Full Text] [Related]
37. Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER-Medicare analysis.
Sadetsky N; Hernandez A; Wallick CJ; McKenna EF; Surinach A; Colburn DE
Cancer Med; 2020 Sep; 9(17):6216-6224. PubMed ID: 32667719
[TBL] [Abstract][Full Text] [Related]
38. Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas.
Park ES; Kwon DH; Park JB; Lee DH; Cho YH; Kim JH; Kim CJ
J Neurosurg; 2014 Dec; 121 Suppl():102-9. PubMed ID: 25434943
[TBL] [Abstract][Full Text] [Related]
39. CNS metastases in breast cancer.
Lin NU; Bellon JR; Winer EP
J Clin Oncol; 2004 Sep; 22(17):3608-17. PubMed ID: 15337811
[TBL] [Abstract][Full Text] [Related]
40. Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study.
Baffert S; Cottu P; Kirova YM; Mercier F; Simondi C; Bachelot T; Le Rhun E; Levy C; Gutierrez M; Madranges N; Moldovan C; Coudert B; Spaëth D; Serin D; Cotté FE; Benjamin L; Maillard C; Laulhere-Vigneau S; Durand-Zaleski I
BMC Health Serv Res; 2013 Oct; 13():456. PubMed ID: 24176086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
